Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024

Rhea-AI Summary

Edgewise Therapeutics, Inc. (Nasdaq: EWTX) will present at the J.P. Morgan 42nd Annual Healthcare Conference on January 9, 2024. The presentation will be webcast live and accessible for replay. Users are advised to connect to the webcast early for a timely connection.

BOULDER, Colo.--(BUSINESS WIRE)-- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced that management will present at the J.P. Morgan 42^nd Annual Healthcare Conference on Tuesday, January 9, 2024, at 10:30 am PT (1:30 pm ET).

The presentation will be webcast live; a link for the webcast can be found on the Edgewise events page and will be accessible for replay following the presentation. It is recommended that users connect to the webcast several minutes prior to the start to ensure a timely connection.

About Edgewise Therapeutics

Edgewise Therapeutics is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s deep expertise in muscle physiology is driving a new generation of first-in-class therapeutics. EDG-5506 is an orally administered skeletal myosin inhibitor in clinical trials in patients with Becker, Duchenne, and Limb-Girdle muscular dystrophies as well as McArdle Disease. EDG-7500, currently in a Phase 1 trial, is a novel cardiac sarcomere modulator for the treatment of HCM and other disorders of cardiac diastolic dysfunction. The entire team at Edgewise is dedicated to our mission: changing the lives of patients and families affected by serious muscle diseases. To learn more, go to: www.edgewisetx.com or follow us on LinkedIn, X (formerly Twitter), Facebook, Instagram and Threads.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231219829381/en/

Investors & Media

Michael Carruthers

Chief Financial Officer

ir@edgewisetx.com

Source: Edgewise Therapeutics

FAQ

When will Edgewise Therapeutics, Inc. (EWTX) present at the J.P. Morgan 42nd Annual Healthcare Conference?

Edgewise Therapeutics, Inc. (EWTX) will present at the J.P. Morgan 42nd Annual Healthcare Conference on Tuesday, January 9, 2024.

What time will the presentation be?

The presentation will be at 10:30 am PT (1:30 pm ET).

Where can the webcast link be found?

The webcast link can be found on the Edgewise events page.

Will the webcast be accessible for replay?

Yes, the webcast will be accessible for replay following the presentation.

What is the recommendation for users regarding the webcast connection?

Users are recommended to connect to the webcast several minutes prior to the start to ensure a timely connection.